The FDA recently issued a draft guidance on how drug and device companies can respond to requests about off-label uses of their products. Alas, it doesn't specifically address many of the key issues relative to social media (referred to in the document as “emerging electronic media”), such as adverse events, the question of property owner vs. property user, and a more precise discussion of what “sponsored” means. Nevertheless, there are lessons to be learned if you are willing to read ...